Ian Michael Estepan insider trades
Open-market stock purchases and sales by Ian Michael Estepan, Chief Operating Officer at Sarepta Therapeutics, Inc, from SEC Form 4 filings since Dec 14, 2020.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 11, 2026 | SRPT Sarepta Therapeutics, Inc | Sold (not open market) | $18.7K |
| Mar 9, 2026 | SRPT Sarepta Therapeutics, Inc | Sold (not open market) | $17.6K |
| Mar 9, 2026 | SRPT Sarepta Therapeutics, Inc | Sold (not open market) | $9.9K |
| Mar 2, 2026 | SRPT Sarepta Therapeutics, Inc | Sold (not open market) | $53.5K |
| Mar 2, 2026 | SRPT Sarepta Therapeutics, Inc | Sold (not open market) | $14.2K |
| Mar 1, 2026 | SRPT Sarepta Therapeutics, Inc | Bought (not open market) | — |
| Feb 26, 2026 | SRPT Sarepta Therapeutics, Inc | Bought (not open market) | — |
| Feb 26, 2026 | SRPT Sarepta Therapeutics, Inc | Bought (not open market) | — |
| Feb 25, 2026 | SRPT Sarepta Therapeutics, Inc | Bought (not open market) | — |
| Dec 16, 2025 | SRPT Sarepta Therapeutics, Inc | Sold | $294K |
Companies traded
- SRPT Sarepta Therapeutics, Inc: 3 sales, last Mar 11, 2026
Get free alerts when Ian Michael Estepan files a new trade →